State of the University Address Set for April 14
Join President Neville Pinto's State of the University Address at Probasco Auditorium April 14.
Make plans to attend the 2022 State of the University Address with President Neville G. Pinto on Thursday, April 14, inside the newly renovated Probasco Auditorium.
Rendering of renovated Probasco Auditorium at 2839 Clifton Avenue.
Refreshments will be available at 2 p.m., and President Pinto's speech will begin at 2:30 p.m. The Spring All-University Faculty meeting will immediately follow.
Probasco Auditorium is located at 2839 Clifton Avenue. The recently completed Probasco Auditorium and classroom space resulted from UC's effort to transform the former Second Church of Christ Scientist building at the corner of Clifton Avenue and Probasco Street.
Those who are unable to join in person can join virtually using this link (Password: FacSen414).
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.